{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T09:09:43Z","timestamp":1778490583949,"version":"3.51.4"},"reference-count":3,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T00:00:00Z","timestamp":1773878400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"SJJ Solutions provided funding for the equipment and study drug."}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1038\/s41433-026-04414-3","type":"journal-article","created":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T13:01:09Z","timestamp":1773925269000},"page":"1082-1083","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Time for refrigerated syringes of biologics to reach room temperature before intravitreal injection"],"prefix":"10.1038","volume":"40","author":[{"given":"Morten Carstens","family":"Moe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bas","family":"van Hal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5765-2008","authenticated-orcid":false,"given":"Gustavo Barreto","family":"Melo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1259-0653","authenticated-orcid":false,"given":"\u00d8ystein Kalsnes","family":"J\u00f8rstad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,19]]},"reference":[{"key":"4414_CR1","doi-asserted-by":"publisher","DOI":"10.1186\/s40942-021-00307-7","volume":"7","author":"WJ Anderson","year":"2021","unstructured":"Anderson WJ, da Cruz NFS, Lima LH, Emerson GG, Rodrigues EB, Melo GB. Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review. Int J Retina Vitreous. 2021;7:37.","journal-title":"Int J Retina Vitreous"},{"key":"4414_CR2","unstructured":"Felleskatalogen: https:\/\/www.felleskatalogen.no\/medisin (accessed 2025.21.11) 2025."},{"key":"4414_CR3","doi-asserted-by":"crossref","unstructured":"Roche: https:\/\/medically.roche.com (accessed 2025.21.11) 2025.","DOI":"10.4000\/145n5"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04414-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04414-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T08:29:23Z","timestamp":1778488163000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41433-026-04414-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,19]]},"references-count":3,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["4414"],"URL":"https:\/\/doi.org\/10.1038\/s41433-026-04414-3","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,19]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"MCM: Bayer (consultant), Roche (consultant, speaker), and SJJ Solutions (consultant, royalties, speaker). BvH: SJJ Solutions (employee). GBM: 4DMT (research support), Bayer (speaker), EyePoint Pharmaceuticals (research support), SJJ Solutions (consultant, research support). \u00d8KJ: AbbVie (consultant, speaker), Bayer (consultant, speaker), Chiesi Farmaceutici (speaker), Haag-Streit (research support), Horus Pharma (consultant), Roche (consultant, funding), and SJJ Solutions (consultant, royalties, speaker).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}